We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy.
- Authors
Hsiao, Sheng-Yen; Tang, Chih-Hsin; Chen, Po-Chun; Lin, Tien-Huang; Chao, Chia-Chia
- Abstract
Melatonin, a naturally biosynthesized molecule secreted by the pineal gland, exhibits antitumor activities against several different types of cancer. The mechanisms of action of melatonin against tumor progression involve cellular apoptosis, antimetastatic activity, antioxidant and mutagenic effects, antiangiogenic activity, and the restoration of cancer immune surveillance. Melatonin has anticancer activity when administered alone or in combination with standard chemotherapeutic agents, with measurable improvements seen in the clinical endpoints of tumor regression and patient survival. However, scant clinical evidence supports the use of melatonin in bladder cancer treatment. Our study has found that melatonin treatment suppresses the bladder cancer cell migratory ability by inhibiting the epithelial-mesenchymal transition (EMT) process, which appears to be linked to melatonin-induced decreases in bladder cancer cell autophagy. Finally, an evaluation of in vivo melatonin-induced antitumor effects in an orthotopic animal model of bladder cancer indicated that melatonin treatment slightly prolonged the survival of tumor-bearing mice. Our study offers novel insights into the use of melatonin in bladder cancer treatment.
- Subjects
BLADDER cancer; MELATONIN; AUTOPHAGY; PINEAL gland; NEOVASCULARIZATION inhibitors
- Publication
Molecules, 2022, Vol 27, Issue 24, p8649
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules27248649